We are a research group working at the interface of chemistry and biology to design probes and inhibitors to investigate the intricate workings of human proteins and cells, with particular interest in epigenetics and dementia. We form part of Alzheimer's Research UK Oxford Drug Discovery Institute (ODDI) and Target Discovery Institute in the University of Oxford's Nuffield Department of Medicine.

 
 

Synthesis for Biology and Medicine CDT

Want to learn more about the Oxford CDT in Synthesis for Biology & Medicine? Students and the Directors share their views on this DPhil (PhD) programme.

Home - ODDI

The Alzheimer's Research UK Oxford Drug Discovery Institute (ODDI) couples the deep disease knowledge and biology expertise of the academic community with high quality, innovative drug discovery technologies.